F Hoffmann-la Roche LTD and its Affiliates
Based in DC
AI Overview
With $4.0M in lobbying spend across 32 quarterly filings, F Hoffmann-la Roche LTD and its Affiliates is a significant lobbying presence. Their lobbying covers 8 issue areas. Active from 2018 to 2025.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $572K |
| 2019 | $440K |
| 2020 | $440K |
| 2021 | $635K |
| 2022 | $525K |
| 2023 | $560K |
| 2024 | $460K |
| 2025 | $410K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that F Hoffmann-la Roche LTD and its Affiliates disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid, Taxation, Health Issues, Budget/Appropriations, Pharmacy and 3 more
S.1914 - Protecting Access to Diabetic Testing Supplies Act of 2017
H.R. 4302 - Protecting Access to Medicare Act of 2014
Medical Device Tax; H.R.1892 - Bipartisan Budget Act of 2018;
H.R.1892 - Bipartisan Budget Act of 2018
H.R. 3271 and S.1914 - Protecting Access to Diabetic Testing Supplies Act of 2017.
H.R. xxxx - Regulatory framework for in-vitro clinical tests (unnamed dis
H.R. 1892 - The Bipartisan Budget Act of 2018
S.1914 - Protecting Access to Diabetic Testing Supplies Act of 2017
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.